semaglutide pharmacokinetics Research Progress on Oral in the Treatment of Type 2 Diabetes Clinical Pharmacokinetics of Oral Semaglutide:

PMID: 202 HuXLiRWuWFangKZhuZWangYet al

The most common ones are usually mild and improve over time: Nausea (especially when starting) Diarrhea or constipation Decreased appetite Fatigue during adjustment period Stomach discomfort Serious But Rare Side Effects More serious side effects are uncommon but require medical attention: Severe allergic reactions Pancreatitis (inflammation of the pancreas) Gallbladder problems Low blood sugar (if combined with diabetes medications) Kidney problems Sleep-Related Considerations Some people report temporary sleep changes when starting GLP-1 medications: Initial insomnia or restlessness (usually improves) Changes in dream patterns Temporary fatigue as body adjusts Mood changes that can affect sleep Most sleep-related side effects resolve within a few weeks as your body adapts to the medication

Most fatigue improves within 46 weeks without intervention

Why PT-141 Is Different Unlike medications that only target circulation, PT-141 works on the mind-body connection of arousal , making it appealing for people whose challenges are related to desire, not just physical response

That said, both medications are FDA-approved, effective treatments for obesity and type 2 diabetes and the ideal choice depends on individual patient factors